Doctors and public health officials have repeatedly said COVID-19 risks — including the infection’s potential to cause myocarditis — are greater than COVID-19 vaccines’ risks. U.S. Centers for Disease ...

2024-2025 COVID-19 vaccines reduced hospitalization risk by 40% against JN.1 lineage variants. COVID-19 is still a public threat and health concern. Between 2024 and 2025, an estimated 380,000 to ...

CLEVELAND, Ohio — Nationally, respiratory syncytial virus and COVID-19 activity remains relatively low, due to population immunity, new vaccines for respiratory syncytial virus, and no new virulent ...

This fall, a federal vaccine advisory panel changed recommendations, saying Americans six months and older should discuss the risks and benefits with their health care providers. The move walked back ...

The second stage of the three-part official UK COVID Inquiry—dealing with the response of the four governments of the UK (covering England, Scotland, Wales, and Northern Ireland) to the pandemic—has ...

The Centers for Disease Control and Prevention has issued updated guidance on who should receive the 2025 COVID-19 booster, focusing on people most at risk for severe illness. Under the current ...